🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase II, single-Arm, prospective study of neoadjuvant Icotinib w...
Status
Recruiting
Location
BeijingCancerH
Start Date
2021-10-25
Trial ID
NCT05104788
Treatments Being Tested
EGFR-tyrosine kinase inhibitor(TKI)- ie, erlotinib, gefitinib, icotinib,has...
Status
Unknown
Location
Multiple Locations
Start Date
2015-12
Trial ID
NCT03151161
Treatments Being Tested
This single-arm, open, multicenter clinical study is going to evaluate the ...
Status
Unknown
Location
Department of Pulmonary Medical Oncology, Tianjin Medical University Cancer Hospital
Start Date
2019-07-01
Trial ID
NCT03992885
Treatments Being Tested
The current standard of care for unresectable locally advanced non-small-ce...
Status
Unknown
Location
The people's Hospital of the Guangxi Zhuang Autonomous Region
Start Date
2014-12
Trial ID
NCT02407366
Treatments Being Tested
Objective: To compare the efficacy and safety of chemotherapy plus intercal...
Status
Unknown
Location
Yu Li
Start Date
2014-01
Trial ID
NCT02031601
Icotinib is a first-generation inhibitor of EGFR-tyrosine kinase inhibitor ...
Status
Not Yet Recruiting
Location
Liaoning Cancer Hospital & Institute
Start Date
2022-01-01
Trial ID
NCT05132985
Treatments Being Tested
This is a prospective, open, single-center, phase Ⅱ study to assess the eff...
Status
Unknown
Location
Henan cancer hospital
Start Date
2016-04-13
Trial ID
NCT02737774
Treatments Being Tested